Overexpression of cytochrome P450 1B1 in advanced non-small cell lung cancer: a potential therapeutic target.

Abstract

CYP1B1, EGFR and p53 overexpression are considered to be aggressive biomarkers for NSCLC, indicating that early-staged patients warrant an aggressive treatment when these factors are overexpressed in the cancer cells.